Immunomodulatory effects of ResistAid™: A randomized, double-blind, placebo-controlled, multidose study.

J Am Coll Nutr · 2013 · PMC3856471 · PMID 24219376

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The 4.5 g/day dose of ResistAid also increased the IgG antibody response to the tetanus vaccine and this increase continued to rise by day 60; however, these values did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.